Form 8-K - Current report:
SEC Accession No. 0001104659-24-068253
Filing Date
2024-06-04
Accepted
2024-06-04 16:16:03
Documents
15
Period of Report
2024-05-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2416286d1_8k.htm   iXBRL 8-K 60020
2 EXHIBIT 3.1 tm2416286d1_ex3-1.htm EX-3.1 34962
3 EXHIBIT 3.2 tm2416286d1_ex3-2.htm EX-3.2 217849
  Complete submission text file 0001104659-24-068253.txt   545645

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA elan-20240530.xsd EX-101.SCH 3009
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE elan-20240530_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elan-20240530_pre.xml EX-101.PRE 22355
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2416286d1_8k_htm.xml XML 3676
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Filer) CIK: 0001739104 (see all company filings)

EIN.: 825497352 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38661 | Film No.: 241018254
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)